MedPath

Online survey of patients with progressive fibrosing interstitial lung disease (PF-ILD) in Japan - A study of physician and patient experiences and perceptions of the course of treatment from initial symptom onset to the time of the survey

Not Applicable
Conditions
Progressive fibrosing interstitial lung disease
Registration Number
JPRN-UMIN000050411
Lead Sponsor
ippon Boehringer Ingelheim Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
141
Inclusion Criteria

Not provided

Exclusion Criteria

<Exclusion criteria for physicians> Not applicable <Exclusion criteria for patients> 1) Patients with a confirmed diagnosis of IPF

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath